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Design / Qualitative study. GPs were interviewed after analysing two
audiotaped cardiovascular consultations.
Setting / Primary health care.
Subjects / A sample of 15 GPs who audiotaped 22 consultations.
Main outcome measures / Barriers hampering GPs from following
the guideline.
Results / Data saturation was reached after about 13 interviews. The
25 identified barriers were related to the risk table, the GP or to
environmental factors. Lack of knowledge and poor communication
skills of the GP, along with pressure of work and demanding patients,
cause GPs to deviate from the guideline. GPs regard barriers external
to themselves as most important.
Conclusion / Using the risk table as a key element of the high-risk
approach in primary prevention encounters many barriers. Merely
incorporating risk tables in guidelines is not sufficient for implementa-
tion of the guidelines. Time-efficient implementation strategies dealing
in particular with the communication and presentation of cardiovas-
cular risk are needed.
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New guidelines for cardiovascular risk management
often incorporate risk tables to support the manage-
ment of patients without established cardiovascular
disease (primary prevention). These tables aim to
improve the quality of care by rationalising decisions
on identification and management of patients at high
risk. The cardiovascular risks in these tables are
mostly derived from Framingham data (1,2). Exam-
ples are: the Sheffield table, the New Zealand table and
the joint European and British societies chart (3/6).
Although these tables vary in the way they present
risks, in the cut-off points for high risk and in the data
used to calculate absolute risk, the underlying con-
cepts are largely similar. The tables are used for highly
individualised risk calculation, the so-called high-risk
approach; various demographic and risk factor data
can be integrated to determine a personal risk profile
(Box 1). This approach is entirely different from those
used in the past, when single risk factors were the
starting point (7,8). Another innovative element is that
risk tables can support risk communication, which in
turn could stimulate patient participation and patient
compliance.
As yet, not much is known about the use of risk
tables. While their use has been associated with
significant reduction in systolic blood pressure (7),
barriers relating to their format, and scaling have also
been reported (8,9). We aimed to examine the barriers
that prevent GPs from adopting the cholesterol guide-
line with its incorporated risk tables since a systematic
inventory is crucial for the development of effective
implementation strategies.
METHODS
A qualitative study was conducted in the southern
part of The Netherlands. The first 20 consecutive GPs
who responded to the recruitment letter were eligible
to take part in the study. They were asked to audiotape
two consultations in which the cardiovascular risk
table was used. The transcripts were used to guide the
semi-structured in-depth interviews with the GPs after
1 to 2 weeks. Awareness of the problems they had
encountered in implementing, and motivations for
deviation of the guideline were standard items for the
GPs are advised to use risk tables for an
individualised risk calculation in the primary
prevention of cardiovascular diseases.
. The high-risk approach in primary prevention
encounters many barriers.
. GPs do not regard the risk table as a
supportive tool for patient involvement.
. Training of GPs in risk communication is an
important part of the required active imple-
mentation strategy for risk tables.
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interview. One of the authors (BvS) executed and
audiotaped the interviews that lasted between 30 and
45 min. Two researchers (BvS and TvdW) indepen-
dently examined the transcripts (consultations and
interviews). A constant comparative approach was
adopted in which data were collected and analysed
concurrently, allowing both expected and emergent
themes and ideas to be incorporated and explored in
subsequent interviews. All barriers to implementation
of the guideline, even if mentioned by only one GP,
were recorded. Differences in coding were solved
through consensus.
The ethics committee of the University Hospital of
Maastricht approved the study and written informed




Of the first 20 GPs who responded to the recruiting
letter, 15 were actually interviewed, because data
saturation emerged after 13 interviews and was
definitely reached after 15 interviews. The GPs showed
sufficient variation in demographic and practice
characteristics. GPs interviewed were aged between
37 and 57 years; 2 were female. They worked either in
group practices or had a single-handed practice in
towns, cities or rural areas. The GPs managed to
record 22 consultations within the arranged time (4
weeks). Many non-specific barriers were mentioned
that reflect the tension between guidelines and daily
practice. GPs seem to act as a conduit within the
consultation and regard clinical evidence as a square
peg to fit in the round hole of the patient’s life (10).
Twenty-five barriers were identified as being specific
for cardiovascular risk management. They were di-
vided into three main categories, and several subcate-
gories, each comprising a number of barriers
(summarised in Table I). Where useful, a quote by
the GPs is given to illustrate the barrier.
Barriers relating to the guideline-Risk table as an
instrument (Table I)
The measuring scale of the risk factors in the risk table
was found to be too crude. The scaling should have
been continuous instead of categorical or dichoto-
mous. Moreover, the table suggests a relatively large
health gain from lowering cholesterol levels compared
to smoking cessation. This was regarded as disadvan-
tageous, because smoking cessation should have the
highest priority.
The risk table was difficult to understand and
should have been introduced through special training.
Many GPs did not notice that hereditary predisposi-
tion for CVD was incorporated in the risk table. Its
complexity called into question its value as a risk table,
as a supportive tool for health education or shared
decision-making.
The trouble with such a table is that you can’t discuss it with
patients. Patients are generally not familiar with statistics, so for
nine out of ten of them reading a graph is not something they
Table I. Barriers (n/25) relating to the prevention of CVD in
primary care.
Barriers
Guideline / Risk table as an instrument
Scaling is too crude; should have been continuous
The value of cholesterol as a risk factor is overestimated
Difficult design at first view, need for training
Not a supportive tool for health education or decision-making
Guideline / Content of the risk table (recommendations)
Lack of agreement with other (inter)national risk tables
Cost reduction is not a doctor’s task
Not up to date, especially for diabetes
Too rational for test ordering in daily practice
GP / Attitude
Ambivalence about prescribing statins to smokers
No motivation to spend extra time on explanation
Negative attitude towards preventive care
Strategic testing, rewarding weight loss or compliance
GP / Routines
Still managing single risk factors, first reaction is drug
prescription
Flukes; accidental findings induce repeated testing
GP / Knowledge
Lack of knowledge (guideline, risk presentation, high risk
approach)
GP / Skills
Risk communication is difficult
Shared decision-making is only useful in theory
Environment / Society
Impact of mass media, focus on emotions
Marketing efforts of pharmaceutical industry caused cholesterol
hype
Mounting demand for regular health check-ups
Defensive medicine to prevent claims
Environment / Medical profession
Difference of primary versus secondary care
Greater influence of specialists
Environment / Practice organisation
Risk table is too complex for practice assistants
Risk profiles not fully integrated in the electronic patient record
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are used to. Let alone interpreting tables with red, yellow and
white colours. (GP4)
Barriers relating to the guideline / Content of the risk
table (recommendations)
The GPs were confused by the lack of agreement with
other national risk tables. Although many GPs agreed
that costs should be taken into account, some thought
that decisions had to be based on medical grounds
only, claiming that cost reduction was not the task of a
doctor.
It was felt that the guideline was not up to date,
already lagging behind current practice, especially for
patients with diabetes.
I give all diabetics a statin, regardless of when I made the
diagnosis, whether they are male or female, whether they smoke
or not. Because I regard diabetes mellitus as a vascular disease
(secondary prevention). (GP9)
Some GPs stated that the decision-making concept
underlying the recommendations for case-finding was
too rational and too restrictive for daily practice.
Screening large numbers of patients or repeated
testing was not perceived as a problem, since the
cholesterol test is cheap and can easily be done with
desktop devices. A risk profile without a cholesterol
level was incomplete according to them. GPs often
used a cholesterol test as part of a strategy to
encourage the patient to adopt a healthy lifestyle.
Barriers relating to the GP / Attitude
All GPs commented on the ambivalence they felt
when prescribing statins to smokers, since smoking
cessation would make prescribing statins unnecessary
in many cases. Pressure of time and high workload
resulted in lack of motivation to spend extra time
explaining the individual’s cardiovascular risk and
counselling. After all, most patients come up with
the same questions again and again.
But if I decide not to test them, it just means you spend 10
minutes explaining why it’s not necessary. Three months later
they turn up at your office and say they want it anyway. That
annoys me, especially since I’ve spent an extra 10 minutes on
them. I’ve given up fighting it. (GP8)
The attitude of GPs to primary prevention of cardi-
ovascular diseases varied. It was not always perceived
as their task or it was regarded as too expensive from
the societal perspective. Some GPs failed to see the
health gain anyhow.
If we’d really do primary prevention, you’d have to follow
hundreds of people for maybe ten or thirty years to prevent one
event. And you don’t know who it’s going to be, which is a big
problem because it results in lots of tension and disappointment.
Let the local health authorities take care of that, that’s fine with
me. (GP10)
Barriers relating to the GP / Routines
For some GPs it was difficult to accept the fact that a
single risk factor, in this case cholesterol, is no longer
the starting point for risk management. They were still
focused on managing raised cholesterol levels instead
of absolute risks of CVD. Often their first reaction was
prescription of statins, as this is not time-consuming
and easier than changing an unhealthy lifestyle.
If you see a cholesterol level of 8 in a 48-year-old man, your first
reaction is a statin. But then, if you check the table, it may turn
out he doesn’t need one. That is a different approach. But in the
back of your mind you still think: what if he gets a heart attack
and it then turns out he had a cholesterol level of 8 all the time
and nothing was done about it? (GP6)
Some GPs justified their overuse of diagnostics with
the argument that they had occasionally found low-
risk people with a moderately elevated cholesterol
level. According to them, such accidental findings
(flukes) showed that the guideline does not offer 100%
certainty.
Barriers relating to the GP / Knowledge
Understanding the epidemiological concepts incorpo-
rated in the risk table was felt to be a problem. Besides,
GPs were simply not aware of some of the recommen-
dations, such as the fact that there is a more aggressive
approach to secondary prevention, or that repeated
(annual) testing after a normal test result is unneces-
sary.
Barriers relating to the GP / Skills
Risk communication, i.e. translating the absolute 10-
year cardiovascular risk into ‘patient language’ is
difficult. The GPs’ explanations were often too com-
plex, not tailored to patients’ needs, or they failed to
check the patients’ understanding. The cardiovascular
risk was very frequently overestimated. In some cases
this was done on purpose as a strategy to change
unhealthy behaviour.
Most GPs felt they were in the best position to
evaluate the pros and cons of different interventions
and to decide on the right one. Shared decision-
making was regarded as a theoretical model for which
there was no time in daily practice, and no patients
need to be involved in decision-making. Hence, the
risk table was not seen as a supportive tool for the
process of shared decision-making.
If you have to start explaining these numbers you have to take
your time and talk about costs as well. All those arguments pro
and con, and percentages and all that, that’s a bit too
complicated for me. What does it mean to these people if I
tell them ‘‘You run a 17% risk and this treatment will reduce it
to 13%’’? That’s not an easy one, I can tell you. (GP16)
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Barriers relating to the environment / Society
The popular mass media and the marketing efforts of
the pharmaceutical industry, for instance by distribut-
ing free digital risk tables and desktop analysers, focus
mainly on emotions and less on facts. As a result, the
general public have unrealistic ideas about the con-
tribution of cholesterol to the absolute cardiovascular
risk, and the topic is fraught with anxiety.
This whole cholesterol story is based on people’s anxiety. If
you’re anxious, get your cholesterol level tested. It used to be:
get your blood pressure tested. It’s all to do with anxiety. It is
linked to something it shouldn’t be linked to. (GP5)
Cholesterol screening is not uncommon in the business
community, and insurance companies often demand
it. Employees with elevated cholesterol levels, based on
a single test, are prematurely labelled as at high risk
and sent to their GPs for follow-up. The GPs then
often have to reassure them, since in most cases there
is nothing to worry about, as apart from the slightly
elevated cholesterol level the patient has a low risk
profile. Sometimes the GP’s motivation to prescribe
statins or order cholesterol tests stemmed from
defensive medicine, i.e. to prevent claims in the near
future.
Suppose he gets a myocardial infarction in the future and then
they find a cholesterol level of 8.0. There will always be someone
who says: ‘‘You mean to say he never checked your cholesterol?’’
(GP15)
Barriers relating to the environment / Medical
profession
GPs stated that specialists often ignore the existing
local consensus. There seems to be a difference in
current practice between primary and secondary care,
especially as regards the threshold for prescribing
statins, which seems to be lower in secondary care.
Specialists have greater influence, in the sense that
changing the treatment initiated by a specialist is very
difficult for a GP.
There are lots of people who’ve been to see the cardiologist for
an a-typical angina, who didn’t actually have angina, but a
transiently abnormal lipid spectrum, and who comes back with
a statin. You just try and reverse that. It’s impossible. (GP1)
Barriers relating to the environment / Practice
organisation
Some GPs mentioned that delegating tasks to the
practice assistant was not possible because of the
complex character of the risk table and the lack of
authority for this task.
Insight into existing data about the patient’s risk
profile is a prerequisite for efficient care. So far,
however, reminder systems, risk tables and guideline
recommendations have not been properly integrated
into the electronic patient record.
DISCUSSION
Risk tables are intended to rationalise identification
and management of people at high risk for CVD. The
feasibility of risk tables is open to doubt, since many
barriers to adherence to the risk table in the Dutch
cholesterol guideline and its recommendations were
identified. The majority of GPs regarded barriers
relating to the mass media and the pharmaceutical
industry as important. From the GPs viewpoint, it
leads to demanding patients and increased pressure for
tests and pharmaceutical interventions. A more de-
fensive attitude towards cholesterol testing and statin
prescription is another barrier. Not surprisingly,
frustration was a recurrent theme in the GPs’ com-
ments. Barriers relating to the content and format of
the risk table were also present. Often in discussing the
various options for intervention with patients, the risk
table raised more questions than it answered, with the
integrated cost-effectiveness considerations in particu-
lar hampering the GPs’ work. Lack of skills in risk
communication were not recognised as barriers by the
GPs themselves but were observed in the audiotaped
consultations.
The GPs who took part in this study varied on the
major personal and practice characteristics. They were
possibly more experienced in cardiovascular preven-
tion compared to the average GP, although some of
the GPs expressed that their motivation to participate
was fed by a negative attitude towards cardiovascular
primary prevention. We expect that the barriers in this
perhaps more motivated group can be generalized to
other GPs. The data saturation indicated that we seem
to have covered the relevant barriers perceived by GPs
in working with the guideline.
The high-risk approach to primary prevention was
not always clear to the GPs, this often being a
‘clinically grey area’, as some have called it (11).
Barriers relating to the GP’s attitude and the differ-
ence between primary and secondary care (10), as well
as to differences in practice organisation, have also
been reported by others (12,13). Time constraints were
indeed identified as one of the major profession-
related barriers (14). Complying with all guidelines
on primary prevention would take several hours a day
(15).
What do these results mean for the implementation
of the risk table? The roles of the media and the
pharmaceutical industry are hard to deal with in an
implementation strategy. Many GPs had difficulties
with prescribing statins to persistent smokers owing to
medical/ethical considerations. However, these con-
siderations are difficult to incorporate in the guide-
lines. Redesigning the format of the risk table and a
larger focus on reducing unnecessary repeat tests
rather than on reducing unnecessary diagnostic tests
36 B. van Steenkiste et al.




























































could be helpful, since most patients want to know
their ‘number’. The decision of when to perform a
diagnostic test may also rest on considerations such as
patient preferences (16).
Training GPs in risk communication is important,
e.g. to neutralize the inflated risk perception and
patient expectations. It might be worthwhile to try to
empower the role of the patients by preparing them for
the consultation by developing materials that do not
induce fear (17,18). This may increase the GP’s
perceived effectiveness in changing patient behaviour,
which in turn is associated with improved preventive
care efforts of patients (19,20).
This qualitative study has yielded some essential
input for the development of a risk communication
tool that can be given to the patient to be read at home
to prepare for discussing one’s cardiovascular risk
during the consultation.
The present study also revealed that further research
should focus on the conditions for risk communica-
tion to patients. Insight is needed into the cognitions,
perceptions and preferences of patients in this respect,
if we are to foster successful cardiovascular prevention
in the GP’s office.
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